Zan Teng

First Hospital of China Medical University

Papers

1

Total Citations

3

H-Index

1

About

Dr. Zan Teng is a leading authority in the field of pancreatic oncology, with a specialized focus on the diagnosis and management of pancreatic neuroendocrine neoplasms (pNENs). Their most impactful work includes spearheading the "Chinese Medical Association consensus for standardized diagnosis and treatment of pancreatic neuroendocrine neoplasms" (2023), a landmark document that has already garnered significant attention with 3 citations in its first year. This consensus addresses the critical challenges posed by pNENs—rare, highly heterogeneous tumors that account for approximately 3% of all pancreatic malignancies and are rising in global incidence. Dr. Teng’s contributions have been instrumental in establishing evidence-based protocols for standardized care, bridging gaps in clinical practice, and improving patient outcomes. By synthesizing multidisciplinary expertise, their work provides a vital framework for clinicians navigating the complexities of pNEN diagnosis, staging, and treatment. With a career dedicated to advancing pancreatic tumor research, Dr. Teng continues to shape the field, offering clarity and direction in an area marked by rapid evolution and growing clinical importance. Their efforts underscore a commitment to translating rigorous research into actionable clinical guidelines.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Chinese Medical Association consensus for standardized diagnosis and treatment of pancreatic neuroendocrine neoplasms
3 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 21
🏛 Institutions: First Hospital of China Medical University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago